These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9356823)

  • 21. Gynecomastia during indinavir antiretroviral therapy in HIV infection.
    Toma E; Therrien R
    AIDS; 1998 Apr; 12(6):681-2. PubMed ID: 9583616
    [No Abstract]   [Full Text] [Related]  

  • 22. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
    Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
    N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral chemoprophylaxis after occupational exposure to human immunodeficiency virus.
    Kulwichit W
    Am J Ophthalmol; 1998 Aug; 126(2):328. PubMed ID: 9727539
    [No Abstract]   [Full Text] [Related]  

  • 24. Low urine pH is associated with reduced indinavir crystalluria in indinavir-treated HIV-infected individuals.
    Gagnon RF; Alli AI; Edwardes MD; Watters AK; Tsoukas CM
    Clin Nephrol; 2006 Jan; 65(1):13-21. PubMed ID: 16429837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Kidney colic under Indinavir [correction of indiavir] therapy in HIV infection].
    Junghanss BG
    Praxis (Bern 1994); 1997 Apr; 86(18):767-8. PubMed ID: 9244966
    [No Abstract]   [Full Text] [Related]  

  • 26. Uveitis following administration of the protease inhibitor indinavir to a patient with AIDS.
    Gariano RF; Cooney EL
    Clin Infect Dis; 1997 Mar; 24(3):529. PubMed ID: 9114223
    [No Abstract]   [Full Text] [Related]  

  • 27. [Indinavir-associated lipodystrophy].
    Krautheim A
    Praxis (Bern 1994); 1999 Feb; 88(7):285-7. PubMed ID: 10097649
    [No Abstract]   [Full Text] [Related]  

  • 28. Indinavir-associated hepatitis in patients with advanced HIV infection.
    Vergis E; Paterson DL; Singh N
    Int J STD AIDS; 1998 Jan; 9(1):53. PubMed ID: 9518018
    [No Abstract]   [Full Text] [Related]  

  • 29. [Urinary calculi and indinavir sulfate in patients with HIV infection. Apropos of 4 cases].
    Chefchaouni MC; Thiounn N; Flam T; Zerbib M; Debré B
    J Urol (Paris); 1997; 103(1-2):35-6. PubMed ID: 9765778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pilot study of nevirapine, indinavir, and lamivudine among patients with advanced human immunodeficiency virus disease who have had failure of combination nucleoside therapy.
    Harris M; Durakovic C; Rae S; Raboud J; Fransen S; Shillington A; Conway B; Montaner JS
    J Infect Dis; 1998 Jun; 177(6):1514-20. PubMed ID: 9607828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the combination of hepatitis and indinavir potentially dangerous?
    Jeurissen FJ; Schneider MM; Borleffs JC
    AIDS; 1998 Mar; 12(4):441-2. PubMed ID: 9520177
    [No Abstract]   [Full Text] [Related]  

  • 32. Indinavir and bones: does thickness = strength?
    TreatmentUpdate; 2001 Jul; 13(3):6-8. PubMed ID: 11569990
    [No Abstract]   [Full Text] [Related]  

  • 33. Antiretroviral rounds. When success is a pain.
    Bartlett JG; del Rio C
    AIDS Clin Care; 2001 Aug; 13(8):74-5. PubMed ID: 11547461
    [No Abstract]   [Full Text] [Related]  

  • 34. Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005).
    Boyd MA; Srasuebkul P; Khongphattanayothin M; Ruxrungtham K; Hassink EA; Duncombe CJ; Ubolyam S; Burger DM; Reiss P; Stek M; Lange J; Cooper DA; Phanuphak P
    Antivir Ther; 2006; 11(2):223-32. PubMed ID: 16640103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet dysfunction as the cause of spontaneous bleeding in two haemophilic patients taking HIV protease inhibitors.
    Pollmann H; Richter H; Jürgens H
    Thromb Haemost; 1998 Jun; 79(6):1213-4. PubMed ID: 9657450
    [No Abstract]   [Full Text] [Related]  

  • 36. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case report. Intestinal infarction due to vascular catastrophe in an HIV-infected patient.
    Wang L; Molina CP; Rajaraman S
    AIDS Read; 2000 Dec; 10(12):718-21. PubMed ID: 11189743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of total bilirubin with indinavir and lopinavir plasma concentrations in HIV-infected patients receiving three different double-boosted dosing regimens.
    Dicenzo R; Luque A; Larppanichpoonphol P; Reichman R
    J Antimicrob Chemother; 2006 Aug; 58(2):393-400. PubMed ID: 16760191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Merck pushes the envelope with once-daily indinavir.
    TreatmentUpdate; 2001; 12(12):8. PubMed ID: 11570096
    [No Abstract]   [Full Text] [Related]  

  • 40. A once-daily HAART regimen containing indinavir + ritonavir plus one or two nucleoside reverse transcriptase inhibitors (PIPO study).
    Burger DM; Aarnoutse RE; Dieleman JP; Gyssens IC; Nouwen J; de Marie S; Koopmans PP; Stek M; van der Ende ME
    Antivir Ther; 2003 Oct; 8(5):455-61. PubMed ID: 14640393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.